Imbrium Therapeutics L.P. ("Imbrium"), a subsidiary of Purdue Pharma L.P. ("Purdue"), announced results from a Phase 1b clinical signal detection study evaluating the safety and efficacy of the novel ...

Chronic inflammatory diseases are becoming a leading pathology and the main cause of death in Western civilization. Persistent inflammation is thought to be ...